Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADial: Topical Nitroglycerin Prior to Transradial Coronary Angiography
NCT05239013Phase 1Unknown
- Sponsor
- Thomas Jefferson University
- Start
- May 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of nitroglycerin, sponsored by Thomas Jefferson University. Primary endpoints: Change in Systolic Blood Pressure at 45 months, Incidence of Headache at 45 months and 1 more. Status: unknown.
02
Drugs
nitroglycerin
Beyond the preview
Go deeper on NCT05239013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05239013.